Open access
Open access
Powered by Google Translator Translator

RCT | Naltrexone-bupropion and behavior therapy, alone and combined, for binge-eating disorder.

7 Nov, 2022 | 12:27h | UTC

Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial – The American Journal of Psychiatry

News Release: People With Binge-eating Disorder Benefit From Specific Behavioral Therapy and Medication – Yale School of Medicine

Commentary: Behavioral Therapy Plus Naltrexone-Bupropion Combination May Reduce Binge Eating – Psychiatric News Alert

 


Stay Updated in Your Specialty

No spam, just news.